11.20.25 -- A Deep Dive into AI, Patient Recruitment, ICH GCP & More

Artificial intelligence (AI) is delivering impact in clinical strategy, but real success depends on pairing it with high-quality, trustworthy data. Join experts for AI Won’t Replace You — But Clinical Teams Using It Might as they discuss how best to use AI to work smarter, move faster, and stay ahead of the competition.

Artificial intelligence (AI) can help address clinical trial disclosure complexities, but only if supported by human guidance. In Navigating Disclosure Complexity: The Power of Human-Centered AI, experts share how an approach centered on keeping a human in the AI loop is shaping strategies to meet the demands of modern disclosure and transparency.

Gaining a patient’s trust is the first step to trial participation. But that can be difficult when patients are overwhelmed by misinformation or kept in the dark altogether. Find out how to address this in From Cautious to Committed, the first of a three-part webinar series covering strategies across the patient recruitment continuum.

Traditional patient recruitment models often begin too late in the clinical trial process or apply generic strategies that miss the mark. In Built-In Data Advantage, the second of a three-part patient recruitment webinar series, discover how to integrate data and feasibility to avoid these pitfalls.

The patient recruitment arena continues to evolve at a rapid pace, and companies need to keep up with the changes or risk being left behind. The 3rd Generation of Patient Recruitment, the final session of a three-part patient recruitment series, focuses on how to transform patient recruitment planning by taking this evolution into account.

The US and EU recently adopted the updated ICH GCP E6(R3) guidelines for conducting clinical trials. In ICH GCP E6(R3): Navigating the New Era, learn how this reshapes trial conduct with simplified principles, stronger data governance, and a focus on risk-based, patient-centric research.

Failing to comply with clinical trial disclosure rules can leave sponsors open to fines and other penalties. Global Clinical Trial Disclosure Fundamentals – Requirements, Timing, and Enforcement Consequences presents the latest core disclosure requirements and enforcement mechanisms as well as tips on how best to stay compliant.

Global clinical trial registries are complex and ever-changing. Navigating the Clinical Trial Registry Ecosystem — Regional and Global Registry Selection guides you through this landscape, providing harmonization initiatives to improve transparency and data consistency across registries.

Plain language summaries (PLS) are growing in importance as a requirement in global transparency. Focusing on both protocol and results summaries, Beyond Clinical Trial Registration — Plain Language Summaries covers evolving regulatory expectations and best practices for global PLS implementation.